First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects
Clinical trial NCT05937581 · COMPLETED
Trial details
- NCT number
- NCT05937581
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2025-12-04
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.